EMAIL THIS PAGE TO A FRIEND

The Science of the total environment

Pharmaceuticals in the freshwater invertebrate, Gammarus pulex, determined using pulverised liquid extraction, solid phase extraction and liquid chromatography-tandem mass spectrometry.


PMID 25544334

Abstract

The development, characterisation and application of a new analytical method for multi-residue PPCP determination in the freshwater amphipod, Gammarus pulex are presented. Analysis was performed using pulverised liquid extraction (PuLE), solid phase extraction (SPE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Qualitative method performance offered excellent limits of detection at <20 ng g(-1) for 18 out of 29 compounds. For quantitative application, linearity and precision were considered acceptable for 10 compounds across the ng-μg g(-1) range (R2≥0.99; ≤20% relative standard deviation respectively). The method was applied to the analysis of G. pulex and river water sourced from six tributaries of the River Thames. Carbamazepine, diazepam, nimesulide, trimethoprim and warfarin were determined in G. pulex samples at low ng g(-1) (dry weight) concentrations across these sites. Temazepam and diclofenac were also detected, but were not quantifiable. Six pharmaceuticals were quantified in surface waters across the eight sites at concentrations ranging from 3 to 344 ng L(-1). The possibility for confirmatory detection and subsequent quantification of pharmaceutical residues in benthic organisms such as G. pulex will enable further understanding on the susceptibility and ecological effects of PPCPs in the aquatic environment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

P0884
(±)-Propranolol hydrochloride, ≥99% (TLC), powder
C16H21NO2 · HCl
40543
(±)-Propranolol hydrochloride, analytical reference material
C16H21NO2 · HCl
PHR1303
3,4,4` Trichlorocarbanilide (Triclocarban), Pharmaceutical Secondary Standard; Certified Reference Material
C13H9Cl3N2O
A7655
Atenolol, ≥98% (TLC), powder
C14H22N2O3
74827
Atenolol, analytical reference material
C14H22N2O3
1044403
Atenolol, United States Pharmacopeia (USP) Reference Standard
C14H22N2O3
A1340000
Atenolol, European Pharmacopoeia (EP) Reference Standard
C14H22N2O3
B7273
Bezafibrate, ≥98%, solid
C19H20ClNO4
72516
Bezafibrate, analytical reference material
C19H20ClNO4
B1115000
Bezafibrate, European Pharmacopoeia (EP) Reference Standard
C19H20ClNO4
94496
Carbamazepine, analytical standard
C15H12N2O
C0450000
Carbamazepine, European Pharmacopoeia (EP) Reference Standard
C15H12N2O
1093001
Carbamazepine, United States Pharmacopeia (USP) Reference Standard
C15H12N2O
PHR1067
Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
C15H12N2O
C4522
Cimetidine
C10H16N6S
PHR1075
Cimetidine, Pharmaceutical Secondary Standard; Certified Reference Material
C10H16N6S
C2175000
Cimetidine, European Pharmacopoeia (EP) Reference Standard
C10H16N6S
1134062
Cimetidine, United States Pharmacopeia (USP) Reference Standard
C10H16N6S
Y0001130
Cimetidine for peak identification, European Pharmacopoeia (EP) Reference Standard
C10H16N6S
Y0001146
Cimetidine for system suitability, European Pharmacopoeia (EP) Reference Standard
C10H16N6S
Y0001635
Diclofenac for system suitability, European Pharmacopoeia (EP) Reference Standard
C14H10Cl2NNaO2
S0765000
Diclofenac sodium, European Pharmacopoeia (EP) Reference Standard
C14H10Cl2NNaO2
1188800
Diclofenac sodium, United States Pharmacopeia (USP) Reference Standard
C14H10Cl2NNaO2
D6899
Diclofenac sodium salt
C14H10Cl2NNaO2
93484
Diclofenac sodium salt, analytical standard
C14H10Cl2NNaO2
PHR1144
Diclofenac sodium salt, Pharmaceutical Secondary Standard; Certified Reference Material
C14H10Cl2NNaO2
F8514
Flurbiprofen, cyclooxygenase inhibitor
C15H13FO2
F0285200
Flurbiprofen, European Pharmacopoeia (EP) Reference Standard
C15H13FO2
PHR1499
Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material
C15H13FO2
F4381
Furosemide
C12H11ClN2O5S